|

Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis

RECRUITINGPhase 4Sponsored by Cappagh National Orthopaedic Hospital
Actively Recruiting
PhasePhase 4
SponsorCappagh National Orthopaedic Hospital
Started2026-01-29
Est. completion2027-09
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07489521

Summary

This study will be a randomised control trial of the use of intra-articular Arthrosamid® a novel intraarticular hydrogel vs. standard of care (steroid and local anaesthetic) for the non-operative management of knee osteoarthritis.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults
* Symptomatic single side knee pain.
* Patients with diagnosis of knee osteoarthritis radiographic Kellgren and Lawrence system OA grade II-III-IV on x ray or MRI.

Exclusion Criteria:

* Inflammatory conditions,
* Cancer,
* acute infection,
* pregnancy and breastfeeding.
* Uncontrolled diabetes mellitus,
* Joint diseases in the knee, such as rheumatoid arthritis or gout, history of knee surgery with metallic implant.
* If patient has undergone knee arthroscopy in past 6 months.
* Intra-articular injection of corticosteroids during the previous 3 months, intra-articular injection of other drugs, such as hyaluronic acid over the previous 1 year.
* Contraindications for intra-articular injection, such as thrombocytopenia, coagulopathy, articular infection of knee, impairment of immunity.

Conditions4

ArthritisIntraarticular InjectionOsteo Arthritis KneeOsteoarthritis

Interventions1

Steroid Drug

Related trials

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.